A Multicenter, Randomized, Parallel Group, Double-Blind, Placebo-Controlled Phase 2 Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Intravenous Single Injection LC28-0126 Immediately Before PCI (Percutaneous Coronary Intervention) in Patients With STEMI(ST-segment Elevation Myocardial Infarction)
Sponsor study identifier
interventional
60
1 country
1
Study Start
January 2014
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
June 2015
Actual (reported)Study Completion
Not reported
Date not reportedEvaluate the efficacy, Safety and Pharmacokinetics of Intravenous single injection LC28-0126 immediately before PCI (Percutaneous Coronary Intervention) in Patients with STEMI (ST-segment Elevation Myocardial Infarction)
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
Not reported
Date not reportedClick on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
January 2014
Date type not reportedThis date has not been verified as actual or estimated.
February 21, 2014
Actual (reported)February 25, 2014
Actual (reported)June 2015
Actual (reported)AUC of CK-MB for 72 hours post PCI
pre PCI, PCI 0h, 6h, 12h, 18h, 24h, 48h, 72h
AUC of Troponin I and CK for 72h post PCI
pre PCI, PCI 0h, 6h, 12h, 18h, 24h, 48h, 72h
Infarct size and myocardial function assessed by CMR and Echocardiogram
Day 4, 30
LC28-0126 Dose A
LC28-0126 Dose B
LC28-0126 Dose C
Placebo
LC28-0126 Dose A
Seoul National University Hospital
Seoul, South Korea
60 participants (actual enrollment reported by the registry).
First Submitted
February 21, 2014
First Posted
February 25, 2014
Study Start
January 2014
Date type not reportedThis date has not been verified as actual or estimated.
Efficacy, Safety and Tolerability of ATH3G10 in Patients With ST-elevation Myocardial Infarction
Placebo
LC28-0126 Dose B
LC28-0126 Dose C
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
Primary Completion
June 2015
Actual (reported)Last Updated
May 10, 2016
Record last verified: 2015-09
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: